Shining a Light on PBM & The Health Care Innovation Ecosystem

By Ms. Hannah M Clark, Global NetGeneration of Youth Cyberjournalist, with support from Dr. Ronnie Lowenstein, Executive Director Global NetGeneration of Youth

NGY Cyberjournalist Hannah Clark being inspired by the passion of Mr. James Carroll, founder and CEO of THOR Medicine.Recently, I was honored to be invited by Dr. Robert Boege, Executive Director of ASTRA to join ASTRA’s Futurist Dr. Ronnie Lowenstein, and serve as a NetGeneration of Youth Cyberjournalist covering a Congressional Briefing held in the Rayburn House Office Building on October 11, 2018 entitled, “Ending Opioid Use: A New Hope”.  The event was co-sponsored by ASTRA, The World Association for Laser Therapy, NetGeneration of Youth, The Optical Society of America, and thirteen other science and medical organizations.  What an opportunity to learn about PBM, “photobiomodulation,” an innovative medical technology, as well as, to be exposed to the organizational stakeholders who advocate for support of America’s ‘science and technology innovation ecosystem.’

What is PBM and What does it Promise?
When I first heard the term photobiomodulation (PBM) I was confused—initially the word sounded like a lighting technique for theater productions. Then as I started researching, it seemed more like a tool for physics experiments involving light. Only when I attended the Congressional Briefing and heard the first-hand testimony of people who miraculously benefited from using this medical technology did I begin to grasp its far-reaching implications for both revolutionizing health care and for serving as an alternative solution to the prescription opioid crisis.

Read the full news story on usinnovation.org

Posted in Industry, THE FUTURE OF LLLT | Leave a comment

NovoTHOR testimonial: Texas Laser Therapy – Trino Pedraza

Trino Pedraza talks about results for his chronic back and neck pain at Texas Laser Therapy.

View current photobiomodulation therapy training dates in your location.

More NovoTHOR Testimonials

Disclaimer: These comments by healthcare professionals and their patients are solely their own. They are uncompensated personal stories about how they have used, or been impacted by, light therapy. These uses have not been reviewed or cleared by FDA.

Posted in Testimonials, Video of the Week | Leave a comment

NovoTHOR testimonial: Texas Laser Therapy – Garrett Poole

Garrett Poole, Black Belt martial artist and owner of Extreme Martial Arts in New Braunfels came to Texas Laser Therapy looking for help with 3 nagging injuries that wouldn’t heal. He has healed and now is seeing impressive Sports Performance & Recovery benefits from daily use of the NovoTHOR Whole Body Light Pod at Texas Laser Therapy in New Braunfels, TX.

View current photobiomodulation therapy training dates in your location.

More NovoTHOR Testimonials

Disclaimer: These comments by healthcare professionals and their patients are solely their own. They are uncompensated personal stories about how they have used, or been impacted by, light therapy. These uses have not been reviewed or cleared by FDA.

Posted in Testimonials, Video of the Week | Leave a comment

New Technologies, Treatments Can End Opioid Use

Those suffering from America’s opioid crisis recently received two major messages of hope.

On Oct. 24, President Donald Trump signed the Opioid Crisis Response Act (OCRA) into law. Dozens of bills designed to address the diverse aspects of the opioid crisis were consolidated into one strategic and integrated approach.

OCRA received overwhelming bi-partisan support in both Chambers.

HR6, which is now Public Law 115-2716, broke new ground in being the first legislation to mandate aggressive development and adoption of alternative pain treatments that include “innovative medical technologies for pain management.”

On Oct. 11, Congress held its first ever briefing on ending opioid use through “innovative medical technologies for pain management.”

Photobiomodulation (PBM) was the featured technology.

Read the full news story on newsmax.com

Posted in Industry, THE FUTURE OF LLLT | Leave a comment

THOR CEO leads official US Congressional Briefing on Photobiomodulation (PBM)

Washington DC, 11th October, 2018. James Carroll (CEO, THOR Photomedicine), Prof. Praveen Arany (University at Buffalo, NY), Annette Quinn RN (Program Manager, Radiation Oncology, University of Pittsburgh (UPMC) Cancer Center) introduced Photobiomodulation (PBM) to a large gathering of senior policy officials at the Rayburn House Office Building.

James Carroll presented evidence to Congress on the effectiveness of PBM for treating pain and where it can be used in place of opioids. Prof. Praveen Arany explained how and why it works, and Annette Quinn RN gave her first hand experience in treating over 854 patients with Oral Mucositis.

The briefing was a historic step for PBM, moving the conversation forward as members of congress were shown stories by members of the public on how PBM had impacted them and enabled them to live a life free from opioids.

The panel outlined the needs for PBM adoption as

  1. Research grants to fund further basic science experiments, therapeutic dose, and large multicenter clinical trials.
  2. FDA to create a PBM specific product code.
  3. Public and private health insurance reimbursement.

For further information on this event visit www.CongressPBM.com

Posted in Industry, THE FUTURE OF LLLT | Leave a comment

LumiThera and Optos Announce Collaboration to Commercialize the Valeda™ Light Delivery System for Treating Dry Age-Related Macular Degeneration in Europe

LumiThera's Valeda® Light Delivery SystemLumiThera Inc., a commercial-stage medical device company focused on developing photobiomodulation (PBM) therapies for ocular disorders and disease, announced a distribution agreement with Optos Plc, a division of Nikon, Inc., Japan to exclusively distribute the Valeda™ Light Delivery System for the treatment of dry age-related macular degeneration (AMD) in 12 European countries. Optos is recognized as the leading provider of ultra-widefield retinal imaging devices to eyecare professionals for improved patient eye care. The announcement follows the recent CE Mark Certification for the European Union (EU) for the treatment of dry AMD utilizing LumiThera’s Valeda™ Light Delivery System.

“The Distribution agreement with Optos allows LumiThera to begin commercialization throughout Europe and establishes a collaboration with a partner in the retinal imaging area,” stated Clark Tedford, Ph.D., LumiThera President and CEO. “Optos is a global leader in ultra-widefield retinal imaging technologies and we are honored to be working with them to open up a new age in the treatment of AMD.”

“Optos is pleased to add the Valeda™ Light Delivery System to our product range and to further support eye care professionals to diagnose and manage retinal diseases. This arrangement allows our customers to visualize AMD in the far periphery with color and autofluorescence ultra-widefield retinal imaging and provide a PBM treatment for dry AMD. This is very important for the patients who have this complicated, degenerative disease,” stated Robert Kennedy, Chief Executive Officer, Optos.

LumiThera recently sponsored a symposium on PBM in ocular disease and presented final data from the LIGHTSITE I study at the Euretina conference in September 2018 and has a multi-center trial in Europe planned to begin in the near term to further support clinical, anatomical, and patient benefits with the Valeda™ Light Delivery System. The therapy consists of a series of light-based treatments to the retinal cells, resulting in improved energy production and addressing inflammation, ischemia and metabolic dysfunction that contribute to the disease.

View the press release on Lumithera website at www.lumithera.com

Disclosure: I am an investor in Lumithera a) because it successfully treats an unmet medical need, (dry AMD) b) I think it will be the first billion dollar photobiomodulation company.

Posted in Industry | Leave a comment

Testimonial: Dr. Darren Bell

Dr. Darren Bell“I love Thor. The product is great. The seminar was very informative and helpful. And the post-purchase support with Mark and the research assistant has been nothing short of exceptional. I feel like I definitely made the right decision by choosing to purchase a Thor Laser. Thanks.”

Dr. Darren Bell
Chiropractor
New York, USA

View current photobiomodulation therapy training dates in your location.

Posted in Testimonials | Leave a comment